Less Two Business Units, MWG Posts 43-Percent Decline in Q1 Revenue | GenomeWeb

NEW YORK, May 10 (GenomeWeb News) - MWG Biotech this week reported a 43-percent decline in total revenues for the first quarter of 2005, and reaffirmed its commitment to lay off nine staffers by the end of the year.

 

Total receipts for the three months ended March 31 fell to €5 million ($6.5 million) from €8.9 million in the prior-year period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.